Race and Therapeutic Drug Response
- 2 March 1989
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 320 (9) , 588-590
- https://doi.org/10.1056/nejm198903023200909
Abstract
The study by Zhou et al. in this issue of the Journal 1 compares the physiologic effects and the pharmacologic disposition of propranolol in a group of American whites and a group of Orientals of Chinese descent. The reason for the study was the perception that Chinese patients tended to respond to lower doses of propranolol than did Western patients. The surprising finding was not one but two differences — namely, the Chinese subjects responded more strongly to the drug, with a larger reduction in the heart rate and blood pressure, although they also metabolized propranolol more efficiently than did their . . .Keywords
This publication has 6 references indexed in Scilit:
- Racial Differences in Drug ResponseNew England Journal of Medicine, 1989
- Comparison of alprazolam plasma levels in normal Asian and Caucasian male volunteersPsychopharmacology, 1988
- Steady state relative bioavailability and pharmacokinetics of oral propranolol in black and white North AmericansBiopharmaceutics & Drug Disposition, 1988
- Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs.Proceedings of the National Academy of Sciences, 1988
- Biologic determinants of propranolol disposition: Results from 1308 patients in the beta-blocker heart attack trial*Clinical Pharmacology & Therapeutics, 1985
- Polymorphic ability to metabolize propranolol alters 4-hydroxypropranolol levels but not beta blockadeClinical Pharmacology & Therapeutics, 1984